(Q45886935)

English

In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL. (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

0 references

1 reference

based on heuristic

inferred from title

author name string

El-Zawahry A

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

Lu P

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

White SJ

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

Voelkel-Johnson C

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2006

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

Cancer Gene Therapy

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

13

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

281-289

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700905

0 references

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Preferential gene transfer to BBN-induced rat bladder tumor by simple instillation of adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Receptors mediating adenovirus attachment and internalization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

TRAIL-induced signalling and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Gene therapy progress and prospects: adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

A review of depsipeptide and other histone deacetylase inhibitors in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

21 January 2018

Biosafety of in vivo adenovirus-p53 intravesical administration in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700905

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700905

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16167063

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45886935&oldid=1634785793"